337 related articles for article (PubMed ID: 6834350)
21. Effects of two combined monophasic and triphasic ethinylestradiol/gestodene oral contraceptives on natural inhibitors and other hemostatic variables.
Creatsas G; Kontopoulou-Griva I; Deligeoroglou E; Digenopoulou L; Tsangaris A; Kallipolitis G; Milingos S; Michalas S
Eur J Contracept Reprod Health Care; 1997 Mar; 2(1):31-8. PubMed ID: 9678107
[TBL] [Abstract][Full Text] [Related]
22. Sex hormone binding globulin: effect of synthetic steroids on the assay and effect of oral contraceptives.
Bowles SM; Mills RJ
Ann Clin Biochem; 1981 Jul; 18(Pt 4):226-31. PubMed ID: 7197136
[TBL] [Abstract][Full Text] [Related]
23. Effects of newer oral contraceptives on the inhibition of coagulation and fibrinolysis in relation to dosage and type of steroid.
Jespersen J; Petersen KR; Skouby SO
Am J Obstet Gynecol; 1990 Jul; 163(1 Pt 2):396-403. PubMed ID: 2196812
[TBL] [Abstract][Full Text] [Related]
24. Increased fibrinolytic activity during use of oral contraceptives is counteracted by an enhanced factor XI-independent down regulation of fibrinolysis: a randomized cross-over study of two low-dose oral contraceptives.
Meijers JC; Middeldorp S; Tekelenburg W; van den Ende AE; Tans G; Prins MH; Rosing J; Büller HR; Bouma BN
Thromb Haemost; 2000 Jul; 84(1):9-14. PubMed ID: 10928462
[TBL] [Abstract][Full Text] [Related]
25. Effects of long-term gestodene-containing oral contraceptive administration on hemostasis.
Abbate R; Pinto S; Rostagno C; Bruni V; Rosati D; Mariani G
Am J Obstet Gynecol; 1990 Jul; 163(1 Pt 2):424-9. PubMed ID: 2372036
[TBL] [Abstract][Full Text] [Related]
26. Effect of oestrogen dose on whole blood platelet activation in women taking new low dose oral contraceptives.
Norris LA; Bonnar J
Thromb Haemost; 1994 Dec; 72(6):926-30. PubMed ID: 7740465
[TBL] [Abstract][Full Text] [Related]
27. [Influence of progestins on adverse effects of oral contraceptives].
Wynn V
Contracept Fertil Sex (Paris); 1985 Jan; 13(1 Suppl):425-30. PubMed ID: 12280210
[TBL] [Abstract][Full Text] [Related]
28. Metabolic profile of six oral contraceptives containing norgestimate, gestodene, and desogestrel.
Teichmann A
Int J Fertil Menopausal Stud; 1995; 40 Suppl 2():98-104. PubMed ID: 8574257
[TBL] [Abstract][Full Text] [Related]
29. Studies on plasma coagulation and fibrinolysis during oral contraception of various types with special reference to cold activation of factor VII.
Gjonnaess H; Fagerhol MK
Scand J Haematol; 1974; 12(3):232-40. PubMed ID: 4831827
[TBL] [Abstract][Full Text] [Related]
30. Progestational agents and blood coagulation. VIII. Effect of low-dose, alternate-day, estrogen-progestin combinations on blood coagulation factors in man, with a special note on the effect of freezing of blood samples.
Ambrus JL; Courey NG; Browne BJ; Mink IB; Moore RH; Ambrus CM
Am J Obstet Gynecol; 1977 May; 128(2):161-6. PubMed ID: 857675
[TBL] [Abstract][Full Text] [Related]
31. [Evaluation of some blood clotting parameters in relation to the administration of estroprogestins].
Orlandi F; Cattaneo C; Gabasio S; Spandre M; Paccotti P; Rustichelli S
Arch Sci Med (Torino); 1978; 135(4):609-17. PubMed ID: 756722
[TBL] [Abstract][Full Text] [Related]
32. [Hemostatic balance during treatment with the newest contraceptives].
Petersen KR; Skouby SO; Sidelmann J; Jespersen J
Ugeskr Laeger; 1994 Jan; 156(2):187-90. PubMed ID: 8296409
[TBL] [Abstract][Full Text] [Related]
33. Sex steroids and thyroid function tests: the role of estrogen and progestogen.
Miyamoto J
Int J Gynaecol Obstet; 1978; 16(1):28-33. PubMed ID: 83257
[No Abstract] [Full Text] [Related]
34. Oral contraceptives.
Maclennan AH
Curr Ther (Seaforth); 1987 Dec; 28(12):113-22. PubMed ID: 12317413
[TBL] [Abstract][Full Text] [Related]
35. Oral contraceptive estrogen and plasma lipid levels.
Hedlin A; Kuksis A; Geher K
Obstet Gynecol; 1978 Oct; 52(4):430-5. PubMed ID: 714324
[TBL] [Abstract][Full Text] [Related]
36. Oestrogen containing oral contraceptives and antithrombin III activity.
Rákóczi I; Nagy I; Szigetvári I; Losonczy H; Hadnagy J; Gáti I
Acta Physiol Acad Sci Hung; 1974; 45(3-4):281-6. PubMed ID: 4471272
[TBL] [Abstract][Full Text] [Related]
37. [The combined effect of an ethinylestradiol/desogestrel contraceptive combination on blood lipids and parameters of liver function and coagulation].
Massafra C; Capitani S; Bernabei A; Scillone L
Rev Fr Gynecol Obstet; 1988 Apr; 83(4):251-5. PubMed ID: 2969134
[TBL] [Abstract][Full Text] [Related]
38. Incidence of hyperprolactinemia during oral contraceptive therapy.
Reyniak JV; Wenof M; Aubert JM; Stangel JJ
Obstet Gynecol; 1980 Jan; 55(1):8-11. PubMed ID: 7352067
[TBL] [Abstract][Full Text] [Related]
39. Effects of conventional or extended-cycle regimen of an oral contraceptive containing 30 mcg ethinylestradiol and 2 mg dienogest on various hemostasis parameters.
Wiegratz I; Stahlberg S; Manthey T; Sänger N; Mittmann K; Lange E; Mellinger U; Kuhl H
Contraception; 2008 Nov; 78(5):384-91. PubMed ID: 18929735
[TBL] [Abstract][Full Text] [Related]
40. Hemostasis profile in women taking low-dose oral contraceptives.
David JL; Gaspard UJ; Gillain D; Raskinet R; Lepot MR
Am J Obstet Gynecol; 1990 Jul; 163(1 Pt 2):420-3. PubMed ID: 2142579
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
